Ourselves it is still winter. Im always saying when we get these situations and weve been spoiled with sunshine, hashtag sees nald reality. So thats exactly what it is. We are definitely still in winter and we are going to get a brief appearance of some winter precip once we head into tonight. So lets take a look at whats going on. Cause and effect weve got a clipper system and that clipper system is going to cross our area tonight and with it we are looking at a very light dusting or even a wintry mix with a mixture of rain and snow. But it looks like its not going to happen until the overnight hours and linger a little bit until the Early Morning. You can see that that low pressure system is right here to the north and weve got the frontal system to the south of it and you can see the line of rain ahead of it and where the colder air is just here to the south of that system, thats where theyre seeing a little bit of that snowfall right now. But were going to watch this very closely.
Kearney Elects Bob Willen Managing Partner and Chairman tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reaffirmed their buy rating on shares of Kura Oncology (NASDAQ:KURA – Free Report) in a research note published on Monday, Benzinga reports. HC Wainwright currently has a $32.00 target price on the stock. Several other research firms have also weighed in on KURA. StockNews.com lowered Kura Oncology from a hold rating to a […]
StockNews.com cut shares of Kura Oncology (NASDAQ:KURA – Free Report) from a hold rating to a sell rating in a report issued on Monday morning. Other equities analysts also recently issued reports about the company. JMP Securities lifted their target price on Kura Oncology from $22.00 to $32.00 and gave the company a market outperform […]
StockNews.com cut shares of Kura Oncology (NASDAQ:KURA – Free Report) from a hold rating to a sell rating in a research note issued to investors on Monday morning. Several other research firms also recently commented on KURA. Wedbush reiterated an outperform rating and issued a $37.00 price objective on shares of Kura Oncology in a […]